Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada

被引:91
作者
Burchell, AN
Richardson, H
Mahmud, SM
Trottier, H
Tellier, PP
Hanley, J
Coutlée, F
Franco, EL
机构
[1] McGill Univ, Div Canc Epidemiol, Fac Med, Dept Oncol, Montreal, PQ H2W 1S6, Canada
[2] McGill Univ, Fac Med, Dept Epidemiol & Biostat, Montreal, PQ, Canada
[3] Queens Univ, Fac Med, Div Canc Care & Epidemiol, Kingston, ON, Canada
[4] Univ Manitoba, Fac Med, Dept Community Hlth Sci, Winnipeg, MB, Canada
[5] McGill Univ, Fac Med, Dept Family Med, Montreal, PQ, Canada
[6] Ctr Hosp Univ Montreal, Dept Microbiol, Montreal, PQ, Canada
基金
加拿大健康研究院;
关键词
disease transmission; papillomavirus; human; sexually transmitted diseases; uterine cervical neoplasms;
D O I
10.1093/aje/kwj077
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The authors estimated plausible ranges of the probability of human papillomavirus (HPV) transmission per coital act among newly forming couples by using stochastic computer simulation. Comparative empirical data were obtained in 1996-2001 from a cohort study of female university students in Montreal, Canada. Female prevalence and frequency of sexual intercourse and condom use were set equal to those in the cohort. Simulations included 240 combinations of male prevalence, the relative risk for protected versus unprotected sex, and per-act transmission probabilities. Those that produced expected HPV incidence within the 95% confidence interval observed in the cohort were selected. The observed 6-month cumulative incidence following acquisition of a new partner was 17.0% (95% confidence interval: 11.4, 23.0). Expected incidences consistent with those from cohort findings occurred in 54/240 simulations. The range of per-act transmission probabilities was 5-100% (median, 40%). Male HPV prevalence was the same as or greater than that for women in all consistent simulations. Varying condom effectiveness did not produce better-fitting data. This simulation suggests that HPV transmissibility is several-fold higher than that for other viral sexually transmitted infections such as human immunodeficiency virus or herpes simplex virus 2. With high transmissibility, any potential protective effect of condoms would disappear over multiple intercourse acts, underlining the need for an effective HPV vaccine.
引用
收藏
页码:534 / 543
页数:10
相关论文
共 61 条
  • [1] BOOTSTRAPPING THE KAPLAN-MEIER ESTIMATOR
    AKRITAS, MG
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1986, 81 (396) : 1032 - 1038
  • [2] Anderson RM., 1999, SEXUALLY TRANSMITTED, P25
  • [3] A stratified approach to untangling the behavioral/biomedical outcomes conundrum
    Aral, SO
    Peterman, TA
    [J]. SEXUALLY TRANSMITTED DISEASES, 2002, 29 (09) : 530 - 532
  • [4] ARAL SO, 1999, SEXUALLY TRANSMITTED, P39
  • [5] BARNABAS R, 2005, 22 INT PAP C CLIN WO
  • [6] The causal relation between human papillomavirus and cervical cancer
    Bosch, FX
    Lorincz, A
    Muñoz, N
    Meijer, CJLM
    Shah, KV
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) : 244 - 265
  • [7] Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model
    Chakraborty, H
    Sen, PK
    Helms, RW
    Vernazza, PL
    Fiscus, SA
    Eron, JJ
    Patterson, BK
    Coombs, RW
    Krieger, JN
    Cohen, MS
    [J]. AIDS, 2001, 15 (05) : 621 - 627
  • [8] High incidence of cervical human papillomavirus infection in women during their first sexual relationship
    Collins, S
    Mazloomzadeh, S
    Winter, H
    Blomfield, P
    Bailey, A
    Young, LS
    Woodman, CBJ
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2002, 109 (01) : 96 - 98
  • [9] When always isn't enough: implications of the late application of condoms for the validity and reliability of self-reported condom use
    de Visser, RO
    Smith, AMA
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2000, 12 (02): : 221 - 224
  • [10] Cost-effective policies for cervical cancer screening - An international review
    Fahs, MC
    Plichta, SB
    Mandelblatt, JS
    [J]. PHARMACOECONOMICS, 1996, 9 (03) : 211 - 230